FDA Import Refusal 1FX-7006088-4/10002/3 — GLEN MARK PHARMACEUTICALS
The FDA refused shipment 1FX-7006088-4/10002/3 from GLEN MARK PHARMACEUTICALS (India) on Aug 8, 2026. The refused product falls under Drugs and Biologics — TACROLIMUS (IMMUNOSUPPRESSIVE). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 8, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 64TDJ08 TACROLIMUS (IMMUNOSUPPRESSIVE)
- Charges
- 75